Product classification is a critical determinant of regulatory strategy and market access in Canada. Whether a product is regulated as a cosmetic or a Natural Health Product (NHP) defines the applicable requirements under the Food and Drugs Act, including pre-market obligations, evidentiary expectations, labelling standards, and permissible claims.
For many product categories, particularly within skincare and topical formulations, the distinction between cosmetic and therapeutic use is not always clear. As a result, classification must be approached as a structured regulatory assessment rather than a format-based decision.
Establishing the correct classification early in product development is essential to mitigate compliance risk, avoid rework, and support a streamlined path to market.
- Overview of Cosmetic and Natural Health Product (NHP) Regulations in Canada
- Determining Product Classification: Cosmetic vs. NHP
- Key Factors in Product Classification: Cosmetic vs. NHP
- Cosmetic vs. NHP: Key Regulatory Distinctions
- Cosmetic–NHP Interface Products
- How Regulatory Consultants Support Product Classification
- Final Remarks
- FAQ
- Can Health Canada reclassify a product after it is already on the market?
- Does having a Natural Product Number (NPN) automatically make a product compliant?
- Can a product be marketed as a cosmetic in Canada if it is sold as a drug or supplement in another country?
- What happens if a product includes both cosmetic and therapeutic claims?
- Can reformulating a product change its regulatory classification?
Overview of Cosmetic and Natural Health Product (NHP) Regulations in Canada
Before assessing classification in detail, it is important to understand the broader regulatory framework within which these determinations are made. In Canada, product classification is not assessed in isolation. It is grounded in the legislative structure of the Food and Drugs Act and its associated regulations, which establish the requirements that apply once a product falls within a given category.
Regulatory Framework under the Food and Drugs Act
In Canada, cosmetic products and NHPs are regulated under the Food and Drugs Act and its associated regulations. The applicable regulatory framework is determined by product classification and may include the Cosmetic Regulations or the Natural Health Products Regulations.
These regulatory frameworks establish requirements related to safety, quality, and, where applicable, efficacy, and set out the conditions under which products may be manufactured, labelled, and sold in Canada.
The Role of Health Canada in Product Classification
Health Canada is responsible for the administration and enforcement of the Food and Drugs Act and for determining the appropriate classification of products. This determination is based on an assessment of the product’s recommended use or purpose, claims, ingredient composition, and overall representation.
Classification is determined on a case-by-case basis. Where products fall within recognized interface areas between regulatory frameworks, Health Canada evaluates the product as a whole to determine whether it meets the definition of a cosmetic, Natural Health Product, or drug under the Food and Drugs Act and its associated regulations.
Determining Product Classification: Cosmetic vs. NHP
To determine the appropriate classification, it is necessary to first understand how each product category is defined under the Food and Drugs Act and its associated regulations. Health Canada assesses whether a product meets the legal definition of a cosmetic or an NHP based on its recommended use or purpose, claims (and/or health claims), ingredients, and overall representation.
Only products that meet the applicable definition may be regulated and marketed within that category in Canada. Where a product does not align with the definition, it cannot be sold under that framework and may require reformulation, relabelling, or repositioning to meet the requirements of the appropriate regulatory category.
How Health Canada Defines Cosmetics
Under the Food and Drugs Act, a cosmetic is defined as “any substance or mixture of substances manufactured, sold, or represented for use in cleansing, improving, or altering the complexion, skin, hair, or teeth.” This definition captures products whose primary purpose is related to hygiene, grooming, or the enhancement of appearance.
Cosmetics are limited to non-therapeutic purposes and must not be represented for use in the diagnosis, treatment, mitigation, or prevention of a disease, disorder, or abnormal physical state, nor for restoring, correcting, or modifying organic functions. As a result, products that are associated with physiological or pharmacological effects, or that make claims implying a health benefit, fall outside the scope of the Cosmetic Regulations.
How Health Canada Defines NHPs
Under the Natural Health Products Regulations, an NHP is defined as a substance set out in Schedule 1, or a combination of such substances, that is manufactured, sold, or represented for use in diagnosing, treating, mitigating, or preventing a disease, disorder, or abnormal physical state or its symptoms, restoring or correcting organic functions, or maintaining or promoting health.
NHPs must contain at least one medicinal ingredient listed in Schedule 1 and may include non-medicinal ingredients that support the formulation. This category encompasses a wide range of products, including vitamins and minerals, herbal remedies, probiotics, homeopathic medicines, and traditional medicines.
In addition to oral dosage forms, certain topical products may also be classified as NHPs where they are represented for a therapeutic purpose or where their recommended use or purpose aligns with the definition set out in the Regulations.
Applying Category Definitions in Practice
In applying these definitions, Health Canada considers whether the product, as represented, falls within the scope of one regulatory framework or another. Where there is overlap, classification is determined by how the product is positioned in the marketplace and the role of its ingredients within that context. If the product’s representation supports a therapeutic purpose, it will be assessed under the applicable health product framework. If not, it may be regulated as a cosmetic. This interpretive approach ensures that classification reflects the product’s intended use as presented to the consumer.
Key Factors in Product Classification: Cosmetic vs. NHP
Product classification in Canada is not determined by how a product is categorized in other jurisdictions. While a product may be marketed as a cosmetic elsewhere, it must be assessed against the definitions and requirements set out under the Food and Drugs Act and its associated regulations to confirm its classification for the Canadian market.
This determination is based on how the product is represented for sale in Canada and requires consideration of several key factors, including the following.
Recommended Use or Purpose and Claims
The recommended use or purpose, as reflected through product claims and overall representation, is a primary consideration in classification. Products represented solely for cleansing, improving, or altering appearance may meet the definition of a cosmetic. Where claims indicate a therapeutic purpose, such as diagnosing, treating, mitigating, or preventing disease, or restoring or correcting organic functions, the product will generally fall within the scope of the Natural Health Products Regulations or the Food and Drug Regulations.
Ingredient Profile
Ingredient composition is considered in the classification assessment, particularly where ingredients have a recognized medicinal purpose. However, classification is not determined by ingredient presence alone. Health Canada evaluates the role of each ingredient within the context of the product’s recommended use or purpose and overall representation.
Mode of Action
Mode of action may be considered as part of the overall assessment, particularly where it supports or clarifies the intended use of the product. Products that are intended to achieve a pharmacological or physiological effect will generally not meet the definition of a cosmetic and may fall within a health product framework.
Representation and Marketing Context
Health Canada considers the full scope of product representation, including labelling, advertising, and any promotional materials. All representations associated with the product are assessed to determine how it is presented to the consumer and whether it aligns with a cosmetic or therapeutic purpose.
Product Claims (Scope and Interpretation)
In addition to the stated recommended use or purpose, the nature and scope of product claims are assessed in detail. Claims that reference structure or function, or that imply a health benefit beyond appearance, may bring the product within a therapeutic framework. Even where claims appear cosmetic in isolation, their cumulative effect across labelling and marketing materials may influence classification. As such, claims must be evaluated in context to ensure they remain consistent with the intended regulatory category.
Cosmetic vs. NHP: Key Regulatory Distinctions
Cosmetics and Natural Health Products are subject to distinct regulatory frameworks under the Food and Drugs Act and its associated regulations.
Regulatory Approach to Cosmetics
Cosmetics in Canada are regulated under a post-market framework established by the Food and Drugs Act and the Cosmetic Regulations. Pre-market authorization is not required. However, manufacturers and importers must submit a Cosmetic Notification Form (CNF) to Health Canada within 10 days after first sale.
Persons who manufacture or import cosmetics are responsible for ensuring that their products are safe for use under normal or reasonably foreseeable conditions and comply with the requirements set out in the Cosmetic Regulations. This includes adherence to ingredient restrictions outlined in the Cosmetic Ingredient Hotlist and ensuring that products are not represented for a therapeutic purpose.
From a regulatory perspective, compliance is supported through appropriate formulation, accurate product representation, and labelling that meets the requirements of the Cosmetic Regulations.
Regulatory Approach to Natural Health Products
NHPs are regulated under a pre-market authorization framework. Prior to sale in Canada, products must obtain a product licence from Health Canada, supported by evidence demonstrating safety, efficacy, and quality, and are assigned a Natural Product Number (NPN) or DIN-HM.
In addition, parties conducting activities such as manufacturing, packaging, labelling, or importing are required to hold a Site Licence and comply with Good Manufacturing Practices (GMP) as set out in the Natural Health Products Regulations. This reflects a more structured and evidence-based regulatory approach compared to cosmetics.
These differences influence regulatory requirements, development considerations, and timelines to market.
Cosmetic–NHP Interface Products
Certain products fall within the cosmetic–NHP interface, where the applicable regulatory pathway is not immediately evident. This occurs where a product may reasonably align with more than one regulatory definition depending on how it is formulated and represented for sale in Canada. However, products cannot be marketed within this interface.
To be sold in Canada, a product must meet the definition of a single regulatory category and comply with the associated requirements. Where alignment is not achieved, the product must be reformulated, relabelled, or otherwise repositioned to meet the requirements of the appropriate framework.
The interface typically arises where there is overlap between cosmetic and therapeutic functions. This may occur where ingredients have a recognized medicinal purpose, or where the product could be represented for either an appearance-based or health-related use. In these cases, classification is influenced by how the product is developed and represented, rather than by product format alone.
Strategic Implications of the Cosmetic–NHP Interface
At the cosmetic–NHP interface, classification has implications beyond regulatory compliance. Alignment with a specific regulatory category can offer a strategic advantage and should be determined based on the desired speed to market and scope of claims.
Positioning a product as a cosmetic may support a more streamlined pathway to market, but limits the scope of allowable claims. In contrast, pursuing an NHP pathway permits broader, therapeutic representation, but introduces additional pre-market requirements and extended timelines.
Ultimately, this requires balancing commercial objectives with regulatory considerations, including the desired marketing approach and the level of regulatory burden a company is prepared to undertake. As a result, classification at this interface is not only a regulatory determination, but also a key consideration in product development and commercialization strategy.
Common Cosmetic-NHP Interface Products
The cosmetic–NHP interface is often seen in product categories such as anti-acne treatments, anti-dandruff formulations, and functional skincare products that incorporate active or bioactive ingredients. These products can reasonably fit within more than one category, depending on how they are developed and represented for sale in Canada.
For example, a topical cream containing botanical extracts with known anti-inflammatory properties may be considered a cosmetic if it is represented for use in improving the appearance of the skin, such as promoting a more even-looking complexion. However, if that same product is represented for use in reducing inflammation or addressing symptoms associated with a skin condition, it may meet the definition of an NHP.
A similar distinction can be seen with scalp care products. A formulation may be regulated as a cosmetic when represented for cleansing or improving the appearance of the scalp and hair. If it is instead represented for use in controlling dandruff or addressing a scalp condition, it may fall within a different regulatory framework based on its recommended use or purpose.
These examples further highlight that product classification is not determined by formulation alone. Rather, it depends on how the product is represented to the consumer and whether it aligns with the applicable regulatory definition. As a result, similar products may be regulated differently in Canada depending on their intended use and overall presentation.
How Regulatory Consultants Support Product Classification
As demonstrated in this article, classification is a critical step in determining the regulatory pathway for market entry in Canada. Given the interpretive nature of classification under the Food and Drugs Act and its associated regulations, early regulatory input can help ensure that products are appropriately positioned and aligned with the applicable requirements. Regulatory consultants support this process by providing structured assessments and strategic guidance throughout product development.
Early Classification Assessment
A regulatory consultant can support product development by conducting an early classification assessment based on the product’s recommended use or purpose, claims, ingredient composition, and overall representation.
This helps ensure that the product is aligned with the appropriate regulatory framework before formulation and marketing decisions are finalized, reducing the risk of reclassification later in development.
Alignment of Claims, Formulation, and Regulatory Pathway
As discussed, product classification is closely tied to how a product is represented and how its ingredients function within the formulation. Regulatory consultants help align claims, ingredient selection, and product positioning with the intended regulatory category.
This ensures that the product meets the applicable definition under the Food and Drugs Act and its associated regulations, while supporting a clear and compliant pathway to market.
Mitigating Compliance Risk
Misclassification often results in delays, reformulation, relabelling, or enforcement action. Regulatory consultants help identify potential risks early by assessing how the product may be interpreted by Health Canada.
This proactive approach supports compliance and reduces the likelihood of issues arising at the time of notification, licensing, or post-market review.
Supporting Efficient Market Entry
By establishing the correct classification and regulatory strategy early, consultants can help streamline the pathway to market. This includes advising on whether a cosmetic or an NHP pathway is more appropriate based on timelines, claims, and commercial objectives.
Clear regulatory alignment supports more predictable timelines and reduces the need for rework during product launch.
Strategic Advantage in Product Development
Beyond compliance, classification plays a key role in shaping product positioning and commercialization strategy. Regulatory consultants provide insight into how classification impacts claims, labelling, and marketability, helping companies make informed decisions early in development.
Final Remarks
Product classification in Canada is not a fixed attribute of a product, but a regulatory determination shaped by how it is developed and represented. For companies operating within the cosmetic–NHP space, this distinction carries meaningful implications for both compliance and commercial strategy.
A clear understanding of how Health Canada applies legislative definitions supports more informed decision-making and reduces uncertainty at key stages of product development. By approaching classification proactively, companies can better position their products for successful and efficient entry into the Canadian market.
Regulatory Consultants for Cosmetic – NHP Product Classification in Canada
SNI supports companies in navigating the cosmetic–NHP interface through structured classification assessments and end-to-end regulatory strategy. By evaluating recommended use or purpose, claims, ingredient composition, and overall representation, our team helps ensure products are aligned with the appropriate regulatory framework under the Food and Drugs Act and its associated regulations before they enter the Canadian market.
Backed by over 20 years of industry experience and a deep understanding of Health Canada’s classification approach, SNI provides practical guidance that aligns regulatory requirements with commercial objectives. From early-stage product development to market-ready positioning, our team supports compliant, efficient, and strategically positioned product launches. Entering the US market? Our team can support with that as well, including regulatory positioning, claims review, and alignment with applicable FDA requirements to support a consistent and compliant cross-border market strategy.
⬇️ Send us a request to learn more about labelling solutions
FAQ
Can Health Canada reclassify a product after it is already on the market?
Yes. Health Canada may reassess a product’s classification at any time based on how it is represented, including labelling, advertising, and emerging safety or efficacy concerns. If a product is found not to meet the definition of its current category, it may be subject to compliance or enforcement action, including relabelling or removal from the market.
Does having a Natural Product Number (NPN) automatically make a product compliant?
No. An NPN confirms that a product has been authorized for sale as an NHP. However, compliance must be maintained throughout the product lifecycle, including adherence to authorized claims, formulation, labelling, and GMP. Deviations from the approved product licence may result in non-compliance.
Can a product be marketed as a cosmetic in Canada if it is sold as a drug or supplement in another country?
Not necessarily. Product classification in Canada is determined independently under the Food and Drugs Act and its associated regulations. A product’s classification in another jurisdiction does not determine how it will be regulated in Canada. The product must meet the applicable Canadian definition based on its recommended use or purpose and representation.
What happens if a product includes both cosmetic and therapeutic claims?
Where both types of claims are present, the product is generally assessed based on the overall representation. If therapeutic claims are made, the product will typically fall outside the scope of the Cosmetic Regulations and may require authorization under the Natural Health Products Regulations or another applicable framework.
Can reformulating a product change its regulatory classification?
Yes. Changes to formulation, particularly the addition or removal of ingredients with a medicinal purpose, may affect classification. However, reformulation alone is not determinative. The product must also be aligned in terms of its recommended use or purpose and overall representation to meet the definition of the intended regulatory category.
✷ The content on this website, including information presented in this post, is provided for general informational purposes only and does not constitute legal, regulatory, or professional advice. While efforts are made to ensure accuracy, laws and regulations vary by jurisdiction and may change over time. Readers should not rely on this information as a substitute for advice from qualified legal or regulatory professionals. We disclaim any liability for actions taken based on this content, and users are encouraged to seek guidance specific to their circumstances.
